Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
"Callout rates are one of many factors that help to inform our security footprint at every single airport, but again I can tell you, this is going to get worse before it gets better, particularly if w...